- Home
- NGNE vs HRZN Comparison
NGNE vs HRZN Comparison
Compare NGNE & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGNE
- HRZN
- Stock Information
- Founded
- NGNE 2003
- HRZN 2008
- Country
- NGNE United States
- HRZN United States
- Employees
- NGNE N/A
- HRZN N/A
- Industry
- NGNE Biotechnology: Pharmaceutical Preparations
- HRZN Finance/Investors Services
- Sector
- NGNE Health Care
- HRZN Finance
- Exchange
- NGNE Nasdaq
- HRZN Nasdaq
- Market Cap
- NGNE 352.4M
- HRZN 396.1M
- IPO Year
- NGNE N/A
- HRZN 2010
- Fundamental
- Price
- NGNE $22.64
- HRZN $8.85
- Analyst Decision
- NGNE Strong Buy
- HRZN Sell
- Analyst Count
- NGNE 6
- HRZN 6
- Target Price
- NGNE $60.80
- HRZN $9.35
- AVG Volume (30 Days)
- NGNE 481.6K
- HRZN 530.6K
- Earning Date
- NGNE 11-18-2024
- HRZN 10-29-2024
- Dividend Yield
- NGNE N/A
- HRZN 14.91%
- EPS Growth
- NGNE N/A
- HRZN N/A
- EPS
- NGNE N/A
- HRZN N/A
- Revenue
- NGNE $925,000.00
- HRZN $104,553,000.00
- Revenue This Year
- NGNE N/A
- HRZN N/A
- Revenue Next Year
- NGNE N/A
- HRZN $7.48
- P/E Ratio
- NGNE N/A
- HRZN N/A
- Revenue Growth
- NGNE N/A
- HRZN N/A
- 52 Week Low
- NGNE $14.41
- HRZN $8.46
- 52 Week High
- NGNE $74.49
- HRZN $13.73
- Technical
- Relative Strength Index (RSI)
- NGNE 40.23
- HRZN 34.49
- Support Level
- NGNE $21.34
- HRZN $8.65
- Resistance Level
- NGNE $25.35
- HRZN $9.02
- Average True Range (ATR)
- NGNE 2.14
- HRZN 0.20
- MACD
- NGNE 0.88
- HRZN -0.03
- Stochastic Oscillator
- NGNE 38.64
- HRZN 39.39
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services and sustainability industries.